Platform
Company
Complete Blood Count
Review status
Currently under review
Pending specialist review and validation.
Plasma free hemoglobin measures the amount of hemoglobin circulating freely in the liquid part of your blood instead of being contained inside red blood cells. When red blood cells break apart within the bloodstream, they release hemoglobin into plasma. This test helps detect that process, often called intravascular hemolysis.
It is usually performed together with other tests that evaluate hemolysis, such as haptoglobin, lactate dehydrogenase, bilirubin, and a blood smear. Your care team may order it when they want a more direct look at whether red blood cells are breaking down inside your circulation.
Finding free hemoglobin in plasma can point to red blood cell damage in the bloodstream. This can occur with reactions to blood transfusion, some autoimmune conditions, certain medications, infections, or inherited red cell disorders. It is also used to monitor people supported by devices that move blood, such as mechanical heart valves, ventricular assist devices, or extracorporeal support, where friction or shear stress can damage red blood cells.
Tracking this test can help your team identify problems early, reduce complications, and guide next steps. Persistently high values may signal risk to the kidneys or problems with blood flow or device settings, and they prompt closer monitoring and treatment of the underlying cause.
Most healthy individuals have very little to no free hemoglobin in plasma. Your result is interpreted alongside your symptoms and other laboratory tests. A higher result may suggest red blood cells are breaking apart in your bloodstream, but it can also be affected by how the sample was collected or handled.
If your level is unexpectedly high, your clinician may repeat the test to rule out sample-related issues, review your medications, and consider additional tests for hemolysis. People with blood-moving devices may need device checks and adjustments. If you notice dark urine, fatigue, shortness of breath, or yellowing of the skin or eyes, contact your care team promptly so they can evaluate these symptoms in context.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Using a small needle, drawing through an IV, prolonged tourniquet time, or vigorous tube shaking can rupture red cells in the tube and falsely increase plasma free hemoglobin.
Delays in centrifugation, excessive heat or cold, and rough transport can damage cells after collection, leading to spuriously high results.
Mechanical heart valves, ventricular assist devices, ECMO circuits, and dialysis can cause shear stress on red cells. The test is often used to monitor for device-related hemolysis.
Transfusion reactions can release hemoglobin into plasma. Your team may order this test if there are signs of a reaction or unexplained anemia after transfusion.
Drugs such as dapsone, ribavirin, nitrofurantoin, certain antimalarials, and high-dose intravenous immunoglobulin can contribute to hemolysis in susceptible people.
Autoimmune hemolytic anemia, infections, burns, march hemoglobinuria from strenuous exercise, and some inherited red cell disorders can raise plasma free hemoglobin.
Free hemoglobin normally binds to haptoglobin and is cleared. Low haptoglobin or reduced kidney function can change how much free hemoglobin remains in plasma.
Conditions that involve hemolysis during pregnancy, or in people with implanted cardiac devices, may influence results and warrant closer clinical correlation.
References